Hopp til hovedinnhold

Lymfom i CNS

Sist oppdatert: Sist revidert:
Sist revidert av:
  1. Bataille B, Delwail V, Menet E, Vandermarcq P, Ingrand P, Wager M, Guy G, Lapierre F. Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg 2000; 92: 261-6. pmid:10659013 PubMed  
  2. Taylor JW, Flanagan EP, O'Neill BP, Siegal T, Omuro A, Deangelis L, Baehring J, Nishikawa R, Pinto F, Chamberlain M, Hoang-Xuan K, Gonzalez-Aguilar A, Batchelor T, Blay JY, Korfel A, Betensky RA, Lopes MB, Schiff D. Primary leptomeningeal lymphoma: International Primary CNS Lymphoma Collaborative Group report. Neurology. 2013 Oct 9. Epub ahead of print . pmid:24107866 PubMed  
  3. Vargas TC, Thomas RL, Erickson JC. Leptomeningeal Enhancement in a Patient With Progressive Cranial Neuropathies and Lumbosacral Radiculopathies. JAMA Neurol. 2016 Mar 1;73(3):345-6 . pmid: 26810042 PubMed  
  4. Samani A1, Davagnanam I2, Cockerell OC3, Ramsay A4, Patani R5, Chataway J1.. Lymphomatosis cerebri: a treatable cause of rapidly progressive dementia.. J Neurol Neurosurg Psychiatry. 2015; Feb;86(2):: 238-40. pmid: 24847165 PubMed  
  5. Krause MA, English SW, Zalewski NL. Clinical Reasoning: A 70-year-old man with rapid stepwise paraparesis and sensory loss. Neurology. 2020 Feb 11;94(6):e651-e655. PMID: 31992685. PubMed  
  6. Makranz C, Arkadir D, Nachmias B, Gatt ME, Eliahou R, Atlan K, Mordechai A, Goldshmit N, Lossos A. Neurological misdiagnoses of lymphoma. Neurol Sci. 2020 Sep 24. PMID: 32974798. PubMed  
  7. Nabavizadeh SA, Vossough A, Hajmomenian M, Assadsangabi R, Mohan S. Neuroimaging in Central Nervous System Lymphoma. Hematol Oncol Clin North Am. 2016 Aug;30(4):799-821 . pmid:27443998 PubMed  
  8. Scharf EL, Hanson CA, Howard MT, Keegan BM. Serial cerebrospinal fluid examinations to diagnose hematological malignancy causing neurological disease. J Neurooncol. 2016 Aug;129(1):77-83 . pmid:27161251 PubMed  
  9. Ungureanu A, Le Garff-Tavernier M, Costopoulos M, Parratte T, Brinet A, Durand H, Gaultier C, Hurstel R, Alamome I, Sellal F, Ahle G. CSF interleukin 6 is a useful marker to distinguish pseudotumoral CNS inflammatory diseases from primary CNS lymphoma. J Neurol. 2021 Aug;268(8):2890-2894. PMID: 33609156. PubMed  
  10. Scott BJ, Douglas VC, Tihan T, Rubenstein JL, Josephson SA. A systematic approach to the diagnosis of suspected central nervous system lymphoma. JAMA Neurol 2013; 70: 311-9. pmid: 23319132 PubMed  
  11. Kesari NK, Sivakumar S, Kapadia AM, Chen W, Blieden CR, Venkatasubba Rao CP, Suarez JI. Mystery Case: CNS posttransplant lymphoproliferative disorder. Neurology. 2017 Jul 25;89(4):e32-e37 . pmid:28739669 PubMed  
  12. Houillier C, Soussain C, Ghesquières H, Soubeyran P, Chinot O, Taillandier L, Lamy T, Choquet S, Ahle G, Damaj G, Agapé P, Moluçon-Chabrot C, Amiel A, Delwail V, Fabbro M, Jardin F, Chauchet A, Moles-Moreau MP, Morschhauser F, Casasnovas O, Gressin R, Fornecker LM, Abraham J, Marolleau JP, Tempescul A, Campello C, Colin P, Tamburini J, Laribi K, Serrier C, Haioun C, Chebrek S, Schmitt A, Blonski M, Houot R, Boyle E, Bay JO, Oberic L, Tabouret E, Waultier A, Martin-Duverneuil N, Touitou V, Cassoux N, Kas A, Mokhtari K, Charlotte F, Alentorn A, Feuvret L, Le Garff-Tavernier M, Costopoulos M, Mathon B, Peyre M, Delgadillo D, Douzane H, Genet D, Aidaoui B, Hoang-Xuan K, Gyan E. Management and outcome of primary CNS lymphoma in the modern era: An LOC network study. Neurology. 2020 Mar 10;94(10):e1027-e1039. PMID: 31907289 PubMed  
  13. Schmitz N1.. Treatment of primary CNS lymphoma. Blood. 2015; Feb 26;125(9): 1360-. pmid:25721041 PubMed  
  14. Illerhaus G, Kasenda B, Ihorst G, Egerer G, Lamprecht M, Keller U, Wolf HH, Hirt C, Stilgenbauer S, Binder M, Hau P, Edinger M, Frickhofen N, Bentz M, Möhle R, Röth A, Pfreundschuh M, von Baumgarten L, Deckert M, Hader C, Fricker H, Valk E, Schorb E, Fritsch K, Finke J. High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial. Lancet Haematol. 2016 Aug;3(8):e388-97 . pmid:27476790 PubMed  
  15. Ferreri AJM, Cwynarski K, Pulczynski E, et al . Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial. Lancet Haematol. 2017 Oct 17 . pmid:29054815 PubMed  
  16. Schaff LR, Ambady P, Doolittle ND, Grommes C. Primary central nervous system lymphoma: a narrative review of ongoing clinical trials and goals for future studies. Ann Lymphoma. 2021 Mar;5:8. PMID: 33912868 PubMed  
  17. Shao L, Xu C, Wu H, Jamal M, Pan S, Li S, Chen F, Yu D, Liu K, Wei Y. Recent Progress on Primary Central Nervous System Lymphoma-From Bench to Bedside. Front Oncol. 2021 Aug 18;11:689843. PMID: 34485125 PubMed  
  18. Morell AA, Shah AH, Cavallo C, Eichberg DG, Sarkiss CA, Benveniste R, Ivan ME, Komotar RJ. Diagnosis of primary central nervous system lymphoma: a systematic review of the utility of CSF screening and the role of early brain biopsy. Neurooncol Pract. 2019 Dec;6(6):415-423. doi: 10.1093/nop/npz015. Epub 2019 Apr 27. PMID: 31832211 PubMed  
  19. PDQ Adult Treatment Editorial Board. Primary CNS Lymphoma Treatment (PDQ®): Patient Version. 2020 Sep 23. In: PDQ Cancer Information Summaries Internet. Bethesda (MD): National Cancer Institute (US); 2002–. PMID: 26389274. PubMed  
  • Unn Ljøstad, spesialist i nevrologi, professor PhD
  • Åse Mygland, spesialist i nevrologi, professor dr med